Novartis: Novartis' Pluvicto granted FDA approval for expanded prostate cancer use
The authorisation approximately triples the number of patients eligible to receive the therapy
Read full article »
Novartis is a Switzerland-based multinational medicines company that researches and develops generic and pharmaceutical products for the healthcare industry.
Read more